The Alzheimer's Disease Drug Development Pipeline: What's New and What's Coming?

The Center for BrainHealth invites scientists to share their scientific study with students and other researchers at the BrainHealth Frontiers Lunch Lectures. The lectures are heavily science focused and are not intended for a lay audience.

Friday, 9/22/2023 at noon

Registration is free. Please Register to attend this in-person and virtual event.

Jeff Cummings, MD, ScD
University of Nevada - Chair of the ACTC Neuropsychiatric Symptoms Committee

Jeff Cummings, MD, ScD is a world-renowned Alzheimer’s researcher and leader of clinical trials. He has been recognized for his research and leadership contributions in the field of Alzheimer’s disease. In 2018, he was honored with the Leadership and Achievement Award by the International Society of CNS Drug Development, and he received the Bengt Winblad Lifetime Achievement Award from the national Alzheimer’s Association. In 2019, the International Psychogeriatric Association awarded him with the Distinguished Service Award and he received the Alzheimer’s Drug Discovery Foundation’s Melvin R. Goodes Prize that honors an innovative researcher who has made a significant and lasting impact in the field.

The host for this event will be Sandi Chapman, PhD.

The fall 2023 season will be hybrid. Register free of charge for the season and join us for as many talks as you are able.
Center For BrainHealth
2200 West Mockingbird Lane
Dallas, TX 75235